Immune regulation by sphingosine 1-phosphate and its receptors

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 1, 2012, Pages 3-12

  Bode, Constantin ^a   Gräler, Markus H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

FTY720; Lymphocyte egress; Lymphopenia; S1P lyase; Sphingolipid metabolism; Sphingosine kinase

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; FINGOLIMOD; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2;

AUTOIMMUNE DISEASE; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL INFILTRATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTOPENIA; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SPLEEN;

ANIMALS; CAPILLARY PERMEABILITY; CHEMOKINES; HUMANS; IMMUNE SYSTEM; ISOENZYMES; LYMPH NODES; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; SPLEEN;

EID: 84858799217     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-011-0159-5     Document Type: Review

References (98)

1. Allende ML, Sasaki T, Kawai H et al (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279:52487-52492 (Pubitemid 39656625)
2. Allende ML, Tuymetova G, Lee BG et al (2010) S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 207:1113-1124
3. Allende ML, Bektas M, Lee BG et al (2011) Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J Biol Chem 286:7348-7358
4. Alvarez SE, Harikumar KB, Hait NC et al (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084-1088
5. An S, Bleu T, Huang W et al (1997) Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett 417:279-282 (Pubitemid 27511604)
6. Andréani P, Gräler MH (2006) Comparative quantification of sphingolipids and analogs in biological samples by highperformance liquid chromatography after chloroform extraction. Anal Biochem 358:239-246
7. Bagdanoff JT, Donoviel MS, Nouraldeen A et al (2010) Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R, 2S, 3R)-1, 2, 3, 4-tetrahydroxybutyl)-1H-imidazol-2- yl)ethanone oxime (LX2931) and (1R, 2S, 3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4- yl)butane-1, 2, 3, 4-tetraol (LX2932). J Med Chem 53:8650-8662
8. Bankovich AJ, Shiow LR, Cyster JG (2010) CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol Chem 285:22328-22337
9. Bektas M, Allende ML, Lee BG et al (2010) Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. J Biol Chem 285:10880-10889
10. Billich A, Bornancin F, Devay P et al (2003) Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278:47408-47415 (Pubitemid 37523181)
11. Bode C, Sensken SC, Peest U et al (2010) Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem 109:1232-1243
12. Breart B, Ramos-Perez WD, Mendoza A et al (2011) Lipid phosphate phosphatase 3 enables efficient thymic egress. J Exp Med 208:1267-1278
13. Brinkmann V, Davis MD, Heise CE et al (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457 (Pubitemid 34952287)
14. Brinkmann V, Billich A, Baumruker T et al (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883-897
15. Camerer E, Regard JB, Cornelissen I et al (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 119:1871-1879
16. Choi JW, Gardell SE, Herr DR et al (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci USA 108:751-756
17. Christoffersen C, Obinata H, Kumaraswamy SB et al (2011) Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 108:9613-9618
18. Cinamon G, Matloubian M, Lesneski MJ et al (2004) Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 5:713-720 (Pubitemid 39023303)
19. Cinamon G, Zachariah MA, Lam OM et al (2008) Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9:54-62 (Pubitemid 350286204)
20. Cuvillier O, Pirianov G, Kleuser B et al (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803 (Pubitemid 26243122)
21. Förster R, Mattis AE, Kremmer E et al (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047 (Pubitemid 26427987)
22. Förster R, Schubel A, Breitfeld D et al (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33 (Pubitemid 29468627)
23. Golfier S, Kondo S, Schulze T et al (2010) Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4. FASEB J 24:4701-4710
24. Gonzalez-Cabrera PJ, Hla T, Rosen H (2007) Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics. J Biol Chem 282: 7254-7264 (Pubitemid 47093659)
25. Gossens K, Naus S, Corbel SY et al (2009) Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. J Exp Med 206:761-778
26. Gräler MH (2010) Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions. Cell Physiol Biochem 26:79-86
27. Gräler MH, Goetzl EJ (2004) The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 18:551-553
28. Gräler MH, Huang MC, Watson S et al (2005) Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J Immunol 174:1997-2003 (Pubitemid 40223941)
29. Hait NC, Allegood J, Maceyka M et al (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254-1257
30. Hänel P, Andréani P, Gräler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202-1209
31. Huang MC, Watson SR, Liao JJ et al (2007) Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J Immunol 178:6806-6813 (Pubitemid 46847405)
32. Igarashi N, Okada T, Hayashi S et al (2003) Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278:46832-46839 (Pubitemid 37452263)
33. Im DS, Heise CE, Ancellin N et al (2000) Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem 275: 14281-14286 (Pubitemid 30339709)
34. Ishii M, Egen JG, Klauschen F et al (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458:524-528
35. Ishii M, Kikuta J, Shimazu Y et al (2010) Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med 207:2793-2798
36. Jarman KE, Moretti PA, Zebol JR et al (2010) Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1. J Biol Chem285:483-492
37. Jenne CN, Enders A, Rivera R et al (2009) T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med 206:2469-2481
38. Johnson KR, Becker KP, Facchinetti MM et al (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277:35257-35262
39. Kertesz V, Van Berkel GJ (2010) Fully automated liquid extraction-based surface sampling and ionization using a chip-based robotic nanoelectrospray platform. J Mass Spectrom 45:252-260
40. Keul P, Lucke S, von Wnuck Lipinski K et al (2011) Sphingosine-1- phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 108:314-323
41. Kharel Y, Lee S, Snyder AH et al (2005) Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 280:36865-36872 (Pubitemid 41587768)
42. Kobayashi N, Kobayashi N, Yamaguchi A et al (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 284:21192-21200
43. Kohama T, Olivera A, Edsall L et al (1998) Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273:23722-23728 (Pubitemid 28435703)
44. König K, Diehl L, Rommerscheidt-Fuss U et al (2010) Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration. J Immunol 185:1466-1475
45. Lee MJ, Van Brocklyn JR, Thangada S et al (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-1555 (Pubitemid 28217081)
46. Lee YM, Venkataraman K, Hwang SI et al (2007) A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat 84:154-162 (Pubitemid 350030581)
47. Liao JJ, Huang MC, Goetzl EJ (2007) Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate. J Immunol 178:5425-5428
48. Liu H, Sugiura M, Nava VE et al (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275:19513-19520 (Pubitemid 30441543)
49. Liu G, Burns S, Huang G et al (2009) The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 10:769-777
50. Liu G, Yang K, Burns S et al (2010) The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol 11:1047-1056
51. Lo CG, Xu Y, Proia RL et al (2005) Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J Exp Med 201:291-301 (Pubitemid 40189438)
52. Mandala S, Hajdu R, Bergstrom J et al (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346-349 (Pubitemid 34303689)
53. Matloubian M, Lo CG, Cinamon G et al (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360 (Pubitemid 38133663)
54. Mizugishi K, Yamashita T, Olivera A et al (2005) Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25:11113-11121 (Pubitemid 41747151)
55. Niessen F, Schaffner F, Furlan-Freguia C et al (2008) Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452:654-658 (Pubitemid 351483355)
56. O'Brien N, Jones ST, Williams DG et al (2009) Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J Lipid Res 50:2245-2257
57. Ogawa C, Kihara A, Gokoh M et al (2003) Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J Biol Chem 278:1268-1272 (Pubitemid 36790810)
58. Olivera A, Rivera J (2011) An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv Exp Med Biol 716:123-142
59. Olivera A, Mizugishi K, Tikhonova A et al (2007) The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26:287-297 (Pubitemid 46413904)
60. Olivera A, Eisner C, Kitamura Y et al (2010) Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 120:1429-1440
61. Oo ML, Thangada S, Wu MT et al (2007) Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282:9082-9089 (Pubitemid 47093504)
62. Oskeritzian CA, Price MM, Hait NC et al (2010) Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med 207:465-474
63. Pappu R, Schwab SR, Cornelissen I et al (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316:295-298 (Pubitemid 46633109)
64. Paugh SW, Payne SG, Barbour SE et al (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 554:189-193 (Pubitemid 37324838)
65. Pereira JP, Xu Y, Cyster JG (2010) A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PLoS One 5:e9277
66. Pham TH, Okada T, Matloubian M et al (2008) S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28:122-133
67. Pham TH, Baluk P, Xu Y et al (2010) Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 207:17-27
68. Pinschewer DD, Ochsenbein AF, Odermatt B et al (2000) FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164:5761-5770 (Pubitemid 30389819)
69. Prakash H, Luth A, Grinkina N et al (2010) Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. PLoS One 5:e10657
70. Puneet P, Yap CT, Wong L et al (2010) SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 328:1290-1294
71. Pyne NJ, Pyne S (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10:489-503
72. Rathinasamy A, Czeloth N, Pabst O et al (2010) The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J Immunol 185:4072-4081
73. Rivera J, Proia RL, Olivera A (2008) The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat Rev Immunol 8:753-763
74. Roberts R, Sciorra VA, Morris AJ (1998) Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform. J Biol Chem 273:22059-22067 (Pubitemid 28405388)
75. Saba JD, Nara F, Bielawska A et al (1997) The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J Biol Chem 272:26087-26090 (Pubitemid 27458813)
76. Sabbadini RA (2006) Targeting sphingosine-1-phosphate for cancer therapy. Br J Cancer 95:1131-1135
77. Sabbadini RA (2011) Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. Br J Pharmacol 162:1225-1238
78. Schwab SR, Pereira JP, Matloubian M et al (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739 (Pubitemid 41285945)
79. Sensken SC, Bode C, Gräler MH (2009) Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J Pharmacol Exp Ther 328:963-969
80. Sensken SC, Bode C, Nagarajan M et al (2010) Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia. J Immunol 184:4133-4142
81. Sensken SC, Nagarajan M, Bode C et al (2011) Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia. J Immunol 186:3432-3440
82. Shiow LR, Rosen DB, Brdickova N et al (2006) CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:540-544
83. Skoura A, Michaud J, Im DS et al (2011) Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 31:81-85
84. Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1- phosphate in immunity. Nat Rev Immunol 11:403-415
85. Srinivasan S, Bolick DT, Lukashev D et al (2008) Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Diabetes 57:484-493
86. Suzuki S, Enosawa S, Kakefuda T et al (1996) A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200-205 (Pubitemid 26046580)
87. Thangada S, Khanna KM, Blaho VA et al (2010) Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J Exp Med 207:1475-1483
88. Van Brocklyn JR, Gräler MH, Bernhardt G et al (2000) Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95:2624-2629 (Pubitemid 30210542)
89. Venkataraman K, Lee YM, Michaud J et al (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102:669-676 (Pubitemid 351457860)
90. Vogel P, Donoviel MS, Read R et al (2009) Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 4:e4112
91. Walzer T, Chiossone L, Chaix J et al (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 8:1337-1344 (Pubitemid 350131171)
92. Wang F, Okamoto Y, Inoki I et al (2010) Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 120:3979-3995
93. Weber C, Krueger A, Münk A et al (2009) Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice. J Immunol 183:4292-4301
94. Wei SH, Rosen H, Matheu MP et al (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6:1228-1235 (Pubitemid 43045634)
95. Weigert A, Weis N, Brüne B (2009) Regulation of macrophage function by sphingosine-1-phosphate. Immunobiology 214:748-760
96. Wojciak JM, Zhu N, Schuerenberg KT et al (2009) The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen. Proc Natl Acad Sci USA 106:17717-17722
97. Zachariah MA, Cyster JG (2010) Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction. Science 328:1129-1135
98. Zemann B, Kinzel B, Muller M et al (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107:1454-1458 (Pubitemid 43242381)